Terumo India launches TREO Abdominal Stent-graft system

Terumo India, the Indian subsidiary of Japan-based Terumo Corporation, a global leader in medical technology, has announced the launch of the TREO Stent-Graft System, an advanced solution for Endovascular Aneurysm Repair (EVAR).

Designed specifically for the treatment of infrarenal abdominal aortic aneurysms in adults with suitable anatomies, the TREO Stent-Graft System stands out as the only EVAR graft featuring both suprarenal and infrarenal active fixation.

Shishir Agarwal, President and Managing Director of Terumo India, commenting on the launch said, “In India, the prevalence of abdominal aortic aneurysms is rising, with an estimated 1 in 10,000 people affected annually, underscoring the significant need for advanced treatment options.”

TREO is a three-piece design featuring in situ limb adjustability and provides a wide range of aortic device configurations to specifically address the anatomy of each individual patient. It features enhanced proximal sealing for improved stability and leak prevention, superior lock stent technology that offers robust fixation to reduce migration risks, and a flexible design that adapts to challenging and angulated anatomy. This enhances treatment flexibility, ensuring long-term performance and patient safety. Recent clinical studies show lower sac shrinkage and re-intervention rates.

By bringing this innovative EVR, Terumo India continues to set new standards in providing solutions to challenging endovascular aneurysm repair.